Cargando…

Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters

Mycobacterium ulcerans is the bacillus responsible for Buruli ulcer, an infectious disease and the third most important mycobacterial disease worldwide, after tuberculosis and leprosy. M. ulcerans infection is a type of panniculitis beginning mostly with a nodule or an oedema, which can progress to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babonneau, Jérémie, Bréard, Dimitri, Reynaert, Marie-Line, Marion, Estelle, Guilet, David, Saint André, Jean-Paul, Croué, Anne, Brodin, Priscille, Richomme, Pascal, Marsollier, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473063/ https://www.ncbi.nlm.nih.gov/pubmed/31031626 http://dx.doi.org/10.3389/fphar.2019.00378

Ejemplares similares

Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls
por: Reynaert, Marie-Line, et al.
Publicado: (2019)

Photodegradation of the Mycobacterium ulcerans Toxin, Mycolactones: Considerations for Handling and Storage
por: Marion, Estelle, et al.
Publicado: (2012)

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone
por: Song, Ok-Ryul, et al.
Publicado: (2017)

Regulation of Mycolactone, the Mycobacterium ulcerans Toxin, Depends on Nutrient Source
por: Deshayes, Caroline, et al.
Publicado: (2013)

The potent effect of mycolactone on lipid membranes
por: Nitenberg, Milène, et al.
Publicado: (2018)

An Optimized Method for Extracting Bacterial RNA from Mouse Skin Tissue Colonized by Mycobacterium ulcerans
por: Robbe-Saule, Marie, et al.
Publicado: (2017)

Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of Mycobacterium ulcerans infection
por: Foulon, Mélanie, et al.
Publicado: (2020)

Buruli Ulcer Disease in Republic of the Congo
por: Marion, Estelle, et al.
Publicado: (2014)

Development of a Dry-Reagent-Based qPCR to Facilitate the Diagnosis of Mycobacterium ulcerans Infection in Endemic Countries
por: Babonneau, Jérémie, et al.
Publicado: (2015)

Transcriptional adaptation of Mycobacterium ulcerans in an original mouse model: New insights into the regulation of mycolactone
por: Robbe-Saule, Marie, et al.
Publicado: (2021)

Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology
por: Foulon, M., et al.
Publicado: (2020)

A Descriptive Chemical Composition of Concentrated Bud Macerates through an Optimized SPE-HPLC-UV-MS(2) Method—Application to Alnus glutinosa, Ribes nigrum, Rosa canina, Rosmarinus officinalis and Tilia tomentosa
por: Charpentier, Thomas, et al.
Publicado: (2022)

Clinical Features of Spontaneous Partial Healing During Mycobacterium ulcerans Infection
por: Marion, Estelle, et al.
Publicado: (2016)

Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer
por: Tobias, Nicholas J., et al.
Publicado: (2009)

Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease
por: Sarfo, Fred S, et al.
Publicado: (2014)

The chemistry and biology of mycolactones
por: Gehringer, Matthias, et al.
Publicado: (2017)

Correction: Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer
por: Tobias, Nicholas J., et al.
Publicado: (2010)

The Cell Wall-Associated Mycolactone Polyketide Synthases Are Necessary but Not Sufficient for Mycolactone Biosynthesis
por: Porter, Jessica L., et al.
Publicado: (2013)

Recombinant Antibodies against Mycolactone
por: Naranjo, Leslie, et al.
Publicado: (2019)

Monitoring the Secretory Behavior of the Rat Adrenal Medulla by High-Performance Liquid Chromatography-Based Catecholamine Assay from Slice Supernatants
por: De Nardi, Frédéric, et al.
Publicado: (2017)

Comparison of Two Methods, UHPLC-UV and UHPLC-MS/MS, for the Quantification of Polyphenols in Cider Apple Juices
por: Verdu, Cindy F., et al.
Publicado: (2013)

Type-I interferons promote innate immune tolerance in macrophages exposed to Mycobacterium ulcerans vesicles
por: Bernard, Quentin, et al.
Publicado: (2023)

Mycolactone subverts immunity by selectively blocking the Sec61 translocon
por: Baron, Ludivine, et al.
Publicado: (2016)

Mycobacterium ulcerans mycolactones-fungi crosstalking
por: Hammoudi, Nassim, et al.
Publicado: (2019)

Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone
por: Coutanceau, Emmanuelle, et al.
Publicado: (2007)

Spatiotemporal analysis of mycolactone distribution in vivo reveals partial diffusion in the central nervous system
por: Colucci-Guyon, Emma, et al.
Publicado: (2020)

High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice
por: Mangas, Kirstie M., et al.
Publicado: (2020)

Molecular Mechanisms Underpinning the Circulation and Cellular Uptake of Mycobacterium ulcerans Toxin Mycolactone
por: Tello Rubio, Bruno, et al.
Publicado: (2021)

Bioavailability and feasibility of subcutaneous 5-fluorouracil.
por: Borner, M. M., et al.
Publicado: (1993)

Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography
por: Wadagni, Anita, et al.
Publicado: (2015)

A Novel Mycolactone Toxin Obtained by Biosynthetic Engineering
por: Hong, Hui, et al.
Publicado: (2007)

Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria
por: Hong, Hui, et al.
Publicado: (2008)

Mycolactone displays anti-inflammatory effects on the nervous system
por: Isaac, Caroline, et al.
Publicado: (2017)

Protection against Mycobacterium ulcerans Lesion Development by Exposure to Aquatic Insect Saliva
por: Marsollier, Laurent, et al.
Publicado: (2007)

Bioavailability of IgG Administered by the Subcutaneous Route
por: Berger, Melvin, et al.
Publicado: (2013)

Antioxidants Protect Keratinocytes against M. ulcerans Mycolactone Cytotoxicity
por: Grönberg, Alvar, et al.
Publicado: (2010)

Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease
por: Niang, Fatoumata, et al.
Publicado: (2015)

Membrane perturbing properties of toxin mycolactone from Mycobacterium ulcerans
por: López, Cesar A., et al.
Publicado: (2018)

From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone
por: Ricci, Daniela, et al.
Publicado: (2023)

Mycobacterium ulcerans Ecological Dynamics and Its Association with Freshwater Ecosystems and Aquatic Communities: Results from a 12-Month Environmental Survey in Cameroon
por: Garchitorena, Andrés, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kd9mnl2t915cc53cfd6fvgmohu